Screening of Chemosensitizer Candidates Using Natural Extracts |
Ahn, Hee-Jeong
(Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine)
Kim, Ji-Young (Department of Biosciences and Biotechnology, IBST, Konkuk University) Lee, Choong-Hwan (Department of Biosciences and Biotechnology, IBST, Konkuk University) Song, Im-Sook (Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine) Liu, Kwang-Hyeon (Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine) |
1 | Zhang, S., X. Yang, R. A. Coburn and M. E. Morris. 2005. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance proteino. Biochem. Pharmacol. 70, 627-639. DOI ScienceOn |
2 | Zhang, S., X. Yang and M. E. Morris. 2004. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol. 65, 1208-1216. DOI ScienceOn |
3 | Miller, T. P., T. M. Grogan, W. S. Dalton, C. M. Spier, R. J. Scheper and S. E. Salmon. 1991. P-glycoprotein expression in malignant lymphoma and reversan of clinical drug resistance with chemotherapy plus high-dose verapamil. J. Clin. Oncol. 9, 17-24. |
4 | Morris, M. E. and S. Zhang. 2006. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci. 78, 2116-2130. DOI ScienceOn |
5 | Naz, R K., C. R. Bradford and A. C. Menge. 1984. Isoantigenicity of rabbit sperm, testis, and their extracts as demonstrated by Western blot enzyme immunobinding procedure. Arch Androl. 13, 279-287. DOI |
6 | Paek, I. B., H. Y. Ji, M. S. Kim, G. Lee and H. S. Lee. 2006. Metabolism of a new p-glycoprotein inhibitor HM-30181 in rats using liquid chromatography / electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 20, 1457-1462. DOI ScienceOn |
7 | Pilarski, L. M., R. W. Yatscoff, G. F. Murphy and A. R. Belch. 1998. Drug resistance in multiple myeloma: cyclosporine A analogues and their metabolites as potential chemosensitizers. Leukemia. 12, 505-509. DOI ScienceOn |
8 | Rudrappa, T. and H. P. Bais. 2008. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J. Agric. Food Chem. 56, 1955-1962. DOI ScienceOn |
9 | Silverman, J. A. 1998. Multidrug-resistance transporters. Pharm. Biotechnol. 12, 353-386. |
10 | Shi, R, Q. Huang, X. Zhu, Y. B. Ong, B. Zhao, J. Lu, C. N. Ong and H. M. Shen. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol. Cancer Ther. 6, 1338-1347. DOI ScienceOn |
11 | Vaalburg, W., N. H. Hendrikse, P. H. Elsinga, J. Bart and A. van Waarde. 2005. P-glycoprotein activity and biological response. Toxicol. Appl. Pharmacol. 207, 257-260. DOI ScienceOn |
12 | Fox, E. and S. E. Bates. 2007. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor. Expert Rev. Anticancer Ther. 7, 447-459. DOI ScienceOn |
13 | Gerk, P. M. and M. Vore. 2002. Regulation of expression of the multidrug-associated protein 2 (MRP2) and its role in drug disposition. J. Pharmacol. Exp. Ther. 302, 407-415. DOI ScienceOn |
14 | Gottesman, M. M., T. Fojo and S. E. Bates. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48-58. DOI ScienceOn |
15 | Gradhand, U. and R. B. Kim. 2008. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2). Drug Metab. Rev. 40, 317-354. DOI ScienceOn |
16 | Jin, G. Z., H. J. Quan, J. Koyanagi, K. Takeuchi, Y. Miura, F. Komada and S. Saito. 2005. 4'-O-Alkyaloenin derivatives and their sulfates directed toward overcoming multidrug resistance in tumor cells. Cancer Lett. 218, 15-20. DOI ScienceOn |
17 | Jonsson, B., K. Nilsson, P. Nygren and R. Larsson. 1992. SDZ PSC-833-a novel potent in vitro chemosensitizer in multiple myeloma. Anticancer Drugs 3, 641-646. DOI ScienceOn |
18 | Kim, S. H, G. S. Yeo, Y. S. Lim, C. D. Kang, C. M. Kim and B. S. Chung. 1998. Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Exp. Mol. Med. 30, 87-92. DOI ScienceOn |
19 | Kuo, M. T. 2007. Roles of multidrug resistance genes in breast cancer chemoresistance. Adv. Exp. Med. Biol. 608, 23-30. DOI |
20 | Lee, J. S., D. H. Kim, K. H. Liu, T. K. Oh and C. H. Lee. 2005. Identification of flavonoids using liquid chromatography with electrospray ionization and ion trap tandem mass spectrometry with an MS/MS library. Rapid Commun. Mass Spectrom 19, 3539-3548. DOI ScienceOn |
21 | Limtrakul, P. 2007. Curcumin as chemosensitizer. Adv. Exp. Med. Biol. 595, 269-300. DOI |
22 | Allen, J. D., A. van Loevezijn, J. M. Lakhai, M. van der Valk, O. van Tellingen, G. Reid, J. H. Schellens, G. J. Koomen and A. H. Schinkel. 2002. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1, 417-425. DOI |
23 | Bebawy, M. and D. M. Sze. 2008. Targeting P-glycoprotein for effective oral anti-cancer chemotherapeutics. Curr. Cancer Drug Targets 8, 47-52. DOI ScienceOn |
24 | Choi, C. H., K. H. Sun, C. S. An, J. C. Yoo, K. S. Hahm, I. H. Lee, J. K. Sohng and Y. C. Kim. 2002. Reversal of p-glycoprotein-mediated multidrug resistance by 5,6,7,3', 4' -pentamethoxyflavone (Sinensetin). Biochem. Biophys. Res. Commun. 295, 832-840. DOI ScienceOn |
25 | Choi, C. H., J. H. Kim and S. H Kim. 2004. Reversal of p-glycoprotein-mediated MDR by 5,7,3',4',5' -pentamethoxyflavone and SAR. Biochem. Biophys. Res. Commun. 30, 672-679. |
26 | Dantzig, A. H., K. L. Law, J. Cao and J. J. Starling. 2001. Reversal of multidrug resistance by the p-glycoprotein modulator, LY335979, from the bench to the clinic. Curr. Med. Chem. 8, 39-50. DOI ScienceOn |
27 | Higgins, C. F. 2007. Multiple molecular mechanisms for multidrug resistance transporters. Nature 446. 749-757. DOI ScienceOn |